
Détail de l'auteur
Auteur S. PAIN |
Documents disponibles écrits par cet auteur (5)

![]()
Article : Périodique
E. BOUQUET ; S. PAIN ; C. EIDEN ; E. JOUANJUS ; N. RICHARD ; B. FAUCONNEAU ; M. C. PERAULT-POCHAT ; French Addictovigilance Network |Aims: To describe the adverse events (AEs) of recreational cannabis use in France between 2012 and 2017. Methods: AEs related to recreational cannabis use, alone or in combination with alcohol and/or tobacco reported to the French Addictovigila[...]![]()
Article : Périodique
B. SCHRECK ; N. WAGNEUR ; P. CAILLET ; M. GÉRARDIN ; J. CHOLET ; M. SPADARI ; N. AUTHIER ; J. TOURNEBIZE ; M. GAILLARD ; A. SERRE ; L. CARTON ; S. PAIN ; P. JOLLIET ; C. VICTORRI-VIGNEAU |Background: Cannabinoid hyperemesis syndrome is a variant of cyclical vomiting syndrome in a context of chronic cannabis usage. Our aim was to compare French cases to those identified in the international literature in order to further our knowl[...]![]()
Article : Périodique
Observations conducted in France among users of psychoactive substances show that the consumption of hallucinogenic plants and mushrooms is growing. In 2014, 4.8% (3.2% in 2010) of persons aged 18-64 years-old have already used hallucinogenic mu[...]![]()
Article : Périodique
S. PAIN ; F. CHAVANT ; B. FAUCONNEAU ; J. GUENEZAN ; N. MARJANOVIC ; J. Y. LARDEUR ; B. BRUNET ; M. C. PERAULT-POCHAT |"Poppers" (alkyl nitrites) were made famous in the 1960s as a party drug and are still used today. They are highly volatile, sweet-smelling liquids commonly administered by inhalation. However, sometimes, they can be consumed by oral ingestion r[...]![]()
Article : Périodique
E. FRAUGER ; L. POCHARD ; Q. BOUCHERIE ; A. GIOCANTI ; C. CHEVALIER ; A. DAVELUY ; V. GIBAJA ; A. S. CAOUS ; C. EIDEN ; N. AUTHIER ; R. LE BOISSELIER ; M. GUERLAIS ; E. JOUANJUS ; M. LEPELLEY ; V. PIZZOGLIO ; S. PAIN ; N. RICHARD ; J. MICALLEF ; Réseau Français des Centres d'Addictovigilance = French Network of Addictovigilance Centres |FRANÇAIS : La combinaison de plusieurs dispositifs pharmacoépidémiologiques de surveillance est nécessaire pour évaluer l'abus des substances psychoactives (SPA). Le dispositif « observation des produits psychotropes illicites ou détournés de l[...]